Achilles Therapeutics Ltd., of Stevenage, U.K., appointed Elizabeth M. Jaffee, Scott Antonia and Christopher A. Klebanoff to its scientific advisory board.

Artax Biopharma Inc., of Cambridge, Mass., appointed Joseph Lobacki CEO, Chris VanDeusen chief scientific officer, Richard P. Polisson chief medical officer, Karen LaRochelle chief business officer and Andres Gagete chief operating officer.

Immunicum AB, of Stockholm, appointed Peter Hein interim chief financial officer, effective May 18, 2020.

Spirovant Sciences Inc., of Philadelphia, appointed Roland Kolbeck chief scientific officer.

No Comments